Abstracts tagged "quality improvement and women’s health"

Abstract Number: 2283 • 2019 ACR/ARP Annual Meeting
Improving Lactation Knowledge Among Providers Caring for Rheumatology Patients
Brooke Mills¹ and Bonnie Bermas ¹, ¹UT Southwestern Medical Center, Dallas, TX
Background/Purpose: While the benefits of breastfeeding for both the mother and her infant are well established, available resources regarding medication compatibility with lactation are limited. …
Abstract Number: 2418 • 2018 ACR/ARHP Annual Meeting
Awareness of Fertility and Contraception Issues Among Women with Rheumatologic Diseases
Christina Payne¹, Meagan Clark², Sneha Patel³, Tanya Allawh³, Mei-An Ty-Arias², Ashley Davis² and Arundathi ‎ Jayatilleke ‎⁴, ¹Rheumatology, Drexel University COM/ HUH, Philadelphia, PA, ²Drexel University COM, Philadelphia, PA, ³Internal Medicine, Drexel University COM, Philadelphia, PA, ⁴Rheumatology, Drexel University COM, Philadelphia, PA
Background/Purpose: Because many autoimmune conditions preferentially affect women of childbearing age and both disease and treatment can negatively affect pregnancy outcomes, healthcare providers to women…
Abstract Number: 3142 • 2016 ACR/ARHP Annual Meeting
Improving Counseling, Documentation and Adherence to Highly Effective Birth Control in Women on Teratogenic Medications at a Rural Medical Center: A Quality Improvement Initiative
Sonal Bhalla^1,2,3, John Mecchella^1,4 and Alicia Zbehlik^1,4,5, ¹Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ²Rheumatology/ Leardership Peventive Medicine Residency, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ³Instructor in Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, ⁴Geisel School of Medicine at Dartmouth, Hanover, NH, ⁵Leadership Preventive Medicine/Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Autoimmune and inflammatory diseases occur more often in women than in men, and often these women are of childbearing age. Many of the medications…
Abstract Number: 2505 • 2015 ACR/ARHP Annual Meeting
A Fellow Led Quality Improvement Project for Improving Contraceptive Compliance in Women Receiving Teratogenic Medications
Melissa Wells¹, Victoria Lackey², Erica Peart³, Nicholas Holdgate⁴, Samya Mohammad¹, Stephen Balevic¹, Rebecca Sadun⁴, Lisa G. Criscione-Schreiber⁵, Megan E. B. Clowse³ and Mamata Yanamadala⁶, ¹Division of Rheumatology, Department of Medicine, Duke University, Durham, NC, ²Dept of Medicine, Division of Rheumatology, Duke University, Durham, NC, ³Rheumatology, Duke University, Durham, NC, ⁴Rheumatology, Duke University Medical Center, Durham, NC, ⁵Dept of Med/Rheum Div, Duke University, Durham, NC, ⁶Division of Geriatrics, Department of Medicine, Duke University, Durham, NC
Background/Purpose: Women of child bearing age with autoimmune diseases are often prescribed teratogenic medications. Contraceptive compliance in this group of patients has been shown to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].